Last $1.63 USD
Change Today +0.01 / 0.62%
Volume 1.8M
EXEL On Other Exchanges
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pamela A. Simonton J.D., LL.M

Executive Vice President, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Ms. Pamela A. Simonton has been Executive Vice President at Exelixis, Inc. since February 2014. Ms. Simonton served as an Executive Vice President of Exelixis, Inc., since January 2008 and as its Director of Offshore Entities since February 2014. Ms. Simonton served as General Counsel at Exelixis, Inc. until February 2014. Previously, Ms. Simonton served as Senior Vice President, Patents and Licensing from January 2004 until December 2007 and also as Vice President of ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

There is no Board Members Memberships data available.


Miami University
Cardiff and Vale College
Nova Southeastern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$617,636

Stock Options*

All Other Compensation$7,650
Exercisable Options819,687
Exercisable Options Value$131,601
Unexercisable Options288,313
Unexercisable Options Value$117,974
Total Value of Options$318,125
Total Number of Options1,280,000

Total Compensation*

Total Annual Cash Compensation$625,286
Total Short Term Compensation$617,636
Other Long Term Compensation$7,650
Total Calculated Compensation$1,321,616
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $1.63 USD +0.01


James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Raul R. Rodriguez Chief Executive Officer, President and Director
Rigel Pharmaceuticals, Inc.
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at